MedPath

Dorzolamide Hydrochloride and Timolol Maleate

These highlights do not include all the information needed to use DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION.DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATEophthalmic solution, for topical ophthalmic useInitial U.S. Approval: 1998

Approved
Approval ID

be8b1a47-3342-4072-b67c-6d1374d5d4d6

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 7, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dorzolamide Hydrochloride and Timolol Maleate

PRODUCT DETAILS

NDC Product Code72162-2184
Application NumberANDA090604
Marketing CategoryC73584
Route of AdministrationOPHTHALMIC
Effective DateDecember 11, 2023
Generic NameDorzolamide Hydrochloride and Timolol Maleate

INGREDIENTS (8)

DORZOLAMIDE HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: QZO5366EW7
Classification: ACTIM
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULR
Classification: IACT
HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)Inactive
Code: S38J6RZN16
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
TIMOLOL MALEATEActive
Quantity: 5 mg in 1 mL
Code: P8Y54F701R
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dorzolamide Hydrochloride and Timolol Maleate - FDA Drug Approval Details